Patients' Perception and Future Acceptance of an Artificial Pancreas
Open Access
- 1 May 2010
- journal article
- research article
- Published by SAGE Publications in Journal of Diabetes Science and Technology
- Vol. 4 (3), 596-602
- https://doi.org/10.1177/193229681000400313
Abstract
Little is known of patient acceptance of an artificial pancreas (AP). The purpose of this study was to investigate future acceptance of an AP and its determinants. Patients with type 1 diabetes treated with insulin pump therapy were interviewed using questions based on the technology acceptance model and completed the diabetes treatment and satisfaction questionnaire (DTSQ). Twenty-two adults with type 1 diabetes participated. Half of the patients were followed in a university hospital, and the others were under treatment in an affiliated teaching hospital. Half of the patients were male. The mean DTSQ score was 29 (range 23–33). The AP was perceived as likely to be useful. Perceived advantages were a stable glucose regulation, less need for self-monitoring of blood glucose, relief of daily concerns, and time saving. Participants were confident in their capability to use the system. Although many participants (58%) had been reluctant to start continuous subcutaneous insulin infusion, the majority (79%) felt they would have no barriers to start using the AP. Trust in the AP was related to the quality of glucose control it would provide. Almost everyone expressed the intention to use the new system when available, even if it would initially not cover 24/24 hours. The overall attitude on the AP was positive. Intention to use was dependent on trust in the AP, which was related to the quality of glucose control provided by the AP.Keywords
This publication has 15 references indexed in Scilit:
- Can We Really Close the Loop and How Soon? Accelerating the Availability of an Artificial Pancreas: A Roadmap to Better Diabetes OutcomesDiabetes Technology & Therapeutics, 2009
- NICE guidance on continuous subcutaneous insulin infusion 2008: review of the technology appraisal guidanceDiabetic Medicine, 2009
- Continuous Glucose Monitoring and Intensive Treatment of Type 1 DiabetesThe New England Journal of Medicine, 2008
- Naturalistic inquiry and the saturation concept: a research noteQualitative Research, 2008
- Nocturnal hypoglycaemia in Type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associationsDiabetic Medicine, 2007
- Perceptions of Psychosocial Factors and the Insulin PumpDiabetes Care, 2007
- Efficacy of continuous glucose monitoring system (CGMS) to detect postprandial hyperglycemia and unrecognized hypoglycemia in type 1 diabetic patientsDiabetes Research and Clinical Practice, 2007
- Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH‐based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5‐nations trialDiabetic Medicine, 2005
- Youth and Parent Satisfaction With Clinical Use of the GlucoWatch G2 Biographer in the Management of Pediatric Type 1 DiabetesDiabetes Care, 2005
- Continuous Subcutaneous Insulin Infusion Versus Multiple Daily InjectionsDiabetes Care, 2004